CACNG3 and central nervous system cancer: The area under the curve (AUC) was 74.6% and 84.9% respectively in the CGGA datasets (Fig. 3H and I), which indicated that CACNG3 could serve as a potential biomarker of a mesenchymal and neural molecular subtype of the gliomas, while CACNG3 had a more significant ability in predicting neural molecular subtype.